Stock Price
158.65
Daily Change
-2.07%
Yearly
-19.93%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Alcon AG 72.96 0.18 0.25% 28.90%
Almirall SA 10.37 -0.36 -3.36% -3.08%
argenx SE 254.50 -2.80 -1.09% 7.11%
AstraZeneca 8,191.00 -40.00 -0.49% 2.93%
Bayer 44.26 -0.68 -1.51% -7.38%
Genmab 2,457.00 4.00 0.16% 4.87%
Galapagos 41.72 -0.23 -0.55% -58.40%
GN Store Nord 359.10 -11.60 -3.13% -24.24%
GRIFOLS 15.37 -0.24 -1.51% -35.06%
GlaxoSmithKline 1,534.60 0.60 0.04% 10.72%
Hikma Pharmaceutical 2,197.00 -6.00 -0.27% -13.74%
Lonza Group 718.40 1.80 0.25% 32.06%
Merck 213.60 1.10 0.52% 56.31%
Novartis 73.57 -0.23 -0.31% -9.40%
Orion 34.97 -0.72 -2.02% -12.75%
Recordati 53.44 -0.28 -0.52% 22.04%
Roche Holding 362.25 -1.20 -0.33% 19.85%
Sanofi 83.77 -0.42 -0.50% 0.20%
UCB 96.56 -0.14 -0.14% 8.89%
William Demant Holding 303.20 -1.20 -0.39% 40.05%

Indexes Price Day Year
Copenhagen 1754 -6.99 -0.40% 27.87%

H Lundbeck A/S
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.